XM does not provide services to residents of the United States of America.
M
M

MicrochipTechnology

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Microchip Technology says certain operations disrupted by cyber incident

UPDATE 2-Microchip Technology says certain operations disrupted by cyber incident Updates share movement, adds background in paragraphs 4,5, details in paragraph 7 Aug 20 (Reuters) - Microchip Technology MCHP.O said on Tuesday an "unauthorized party" disrupted the company's use of certain servers and some business operations, marking the latest security incident at a U.S.
A
M

Microchip Technology down after saying 'suspicious activity' affected its IT systems

BUZZ-Microchip Technology down after saying 'suspicious activity' affected its IT systems ** Shares of chipmaker Microchip Technology MCHP.O down 2.3% at $78.40 in extended trading ** MCHP says in a regulatory filing it detected a potentially suspicious activity involving its information technology systems on Saturday ** An unauthorized party disru
M

Microchip Technology's certain operations disrupted by cyber incident

Microchip Technology's certain operations disrupted by cyber incident Aug 20 (Reuters) - Microchip Technology MCHP.O said on Tuesday an "unauthorized party" disrupted the company's use of certain servers and some business operations. Reporting by Zaheer Kachwala in Bengaluru; Editing by Shilpi Majumdar
M

Texas Instruments to get $1.6 bln in latest CHIPS Act funding

FACTBOX-Texas Instruments to get $1.6 bln in latest CHIPS Act funding Adds Texas Instruments, Micron, Samsung and TSMC WASHINGTON, Aug 16 (Reuters) - Texas Instruments TXN.O on Friday became the latest semiconductor maker to obtain grants and loans from the U.S. government under President Joe Biden's efforts to supercharge domestic chip production.
B
I
M
M
T

U.S. Advance Auto Parts, Molina Healthcare, Walmart

U.S. RESEARCH ROUNDUP- Advance Auto Parts, Molina Healthcare, Walmart Aug 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advance Auto Parts, Molina Healthcare and Walmart on Friday. HIGHLIGHTS * Advance Auto Parts Inc AAP.N : JP Morgan cuts target price to $55 from $68 * Dare Bioscience Inc DARE.O : Jonestrading raises target price to $13 from $5 * Molina Healthcare Inc MOH.N : Mizuho raises target price to $382
A
A
A
M
A
A
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.